Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(25)
•••
Post by letsdoiton Jun 22, 2020 9:34am
90 Views
Post# 31175923

RE:RE: Lytham Partners virtual investor growth event

RE:RE: Lytham Partners virtual investor growth event Further information regarding the Lytham Partners virtual investor growth event can be found here (see below) A webcast of the presentation will be posted under the investor relations section of LexaGenes website atwww.lexagene.com, or can be accessed athttps://www.webcaster4.com/Webcast/Page/2419/35342orwww.lythampartners.com/virtual. A replay of the presentation will be available following the event. Management will also be participating in virtual one-on-one meetings on June 24 and 25, 2020. To arrange a meeting, please contact Joe Dorame of Lytham Partners atdorame@lythampartners.comor visitwww.lythampartners.com/virtual. To be added to the LexaGene email list, please subscribe on the Companywebsite. On Behalf of the Board of Directors Dr. Jack Regan Chief Executive Officer & Director
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities